
Legal Challenges Likely Following Drug Pricing Executive Order: John Barkett, MBA
John Barkett, MBA, managing director in Berkeley Research Group's Healthcare Transactions and Strategy practice, reiterated that the executive order that President Donald Trump signed on May 12 to lower drug costs could be met with legal challenges …